EN PT


0355/2016 - The essentiality and rationality of medicines included in the Brazilian National Relation of Essential Medicines.
Essencialidade e racionalidade da relação nacional de medicamentos essenciais do Brasil.

Author:

• Sueli Miyuki Yamauti - Yamauti, Sueli Miyuki - são paulo, São Paulo - Universidade Federal de São Paulo (Unifesp) - Hospital Universitário da Universidade Federal de São Paulo, Divisão de Farmácia - <sueli.gmo@epm.br>

Co-author(s):

• Silvio Barberato-Filho - Barberato-Filho, S. - Universidade de Sorocaba, Programa de Pós-Graduação em Ciências Farmacêuticas - <silvio.barberato@prof.uniso.br>
• José Rubem de Alcântara Bonfim - Bonfim, José Rubem de Alcântara - Instituto de Saúde da Secretaria de Estado da Saúde de São Paulo - <jrabonfim@sobravime.org.br>
• Luciane Cruz Lopes - Lopes, L.C. - Piracicaba, SP - Universidade de Sorocaba (UNISO), Pharmaceutical Science Pos graduate Program - <luslopes@terra.com.br>

Thematic Area:

Políticas em Saúde

Abstract:

Purpose: One strategy to implement the rational use of medicines is the adoption of an ‘essential medicines list’ based upon relevant data regarding efficacy, safety, convenience, epidemiology, dosing and cost-effectiveness. The objective of this study was to analyze the list of medicines contained in the Brazilian National Relation of Essential Medicines (Rename, 2013) in terms of essentiality and rationality. Methods: Essentiality was determined by comparing this list to the 18th Essential Medicines List (EML) published by the World Health Organization (WHO). Drugs which were part of the Brazilian National Relation of Essential Medicines but not included in the EML were assessed using the classification described in La revue Prescrire to detect medications without added therapeutic value. Results: It was discovered that the Brazilian National Relation of Essential Medicines contains 190 medications not included in the EML, of which 63 have no added therapeutic value. In addition, discrepancies were identified between the recommendations of the WHO and the drugs included in the Brazilian National Relation of Essential Medicines. Conclusion: It is concluded that drugs that are non-essential and provide no added therapeutic value should not be included in a list of essential medicines funded by the three Brazilian federal entities.

Keywords:

Health policiesEssential medicinesWorld Health OrganizationBrazilBrazilian National Relation of Essential Medicines

Content:

Access Issue in Scielo

Other languages:







How to

Cite

Yamauti, Sueli Miyuki, Barberato-Filho, S., Bonfim, José Rubem de Alcântara, Lopes, L.C.. The essentiality and rationality of medicines included in the Brazilian National Relation of Essential Medicines.. Cien Saude Colet [periódico na internet] (2016/Jul). [Citado em 27/09/2024]. Está disponível em: http://cienciaesaudecoletiva.com.br/en/articles/the-essentiality-and-rationality-of-medicines-included-in-the-brazilian-national-relation-of-essential-medicines/15781?id=15781



Execution



Sponsors